Former FDA Commish Califf Advocates Cosmetics Registration, AE Reporting
This article was originally published in The Rose Sheet
Executive Summary
FDA is hampered in its public safety mission under current law, which does not require cosmetics firms to register marketed products or report adverse events, former agency head Robert Califf says. His June 26 editorial in Jama Internal Medicine accompanies an analysis of FDA's cosmetics adverse-event data.